Manesh Mahadeo Jagtap

Insider activity · 24 months1 buy1 saleCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 1 buy · 1 saleFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 23 Jan 2026 for JB Chemicals & Pharmaceuticals Limited, €134k.

Filing timeline

BuySale

Manesh Mahadeo Jagtap

Manesh Mahadeo Jagtap: trading record in brief

Manesh Mahadeo Jagtap discloses dealings in JB Chemicals & Pharmaceuticals Limited to SEBI (PIT + SAST). We count 4 filings; the first trade dates from 21 January 2026 and the latest from 23 January 2026.

Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The newest entry dates from 23 January 2026: a transaction of €134k, in JB Chemicals & Pharmaceuticals Limited. The median gap between trade and publication is zero days: most filings appear on the same day. This delay matters because a trade only becomes useful information once it is public. This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.